Arkolith/Insider Trading/ETON/Form 4

Adams Jennifer McKie

DirectorEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)50K$3.78$189K50K
Jun 17, 2026Sell(S)50K$32.48$1.6M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)50K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-021000) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML